Viewing Study NCT01132495


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-02 @ 4:23 AM
Study NCT ID: NCT01132495
Status: COMPLETED
Last Update Posted: 2019-09-16
First Post: 2010-05-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
Sponsor: Abbott Medical Devices
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-05
Start Date Type: None
Primary Completion Date: 2014-01
Primary Completion Date Type: ACTUAL
Completion Date: 2015-05
Completion Date Type: ACTUAL
First Submit Date: 2010-05-20
First Submit QC Date: None
Study First Post Date: 2010-05-28
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-06-08
Results First Submit QC Date: None
Results First Post Date: 2016-12-09
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-08-08
Last Update Post Date: 2019-09-16
Last Update Post Date Type: ACTUAL